TAK

#465
Takeda Pharmaceutical Company Limited American Depositary Share
15.9 7 USD
+9782.43%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
15.95
15.98
년간 변동
0.16
18.89
일일 변동
+9782.43%
월간 변동
-4.37%
6달 변화
+10.06%
년간 변동율
+12.58%
이전 종가
0.1 6
Open
15.9 7
저가
15.9 5
High
15.9 8
양
809
전체 차트 열기 Full chart

Financials

개요 성명 통계 배당금
4분기 연간
손익계산서 대차대조표 현금 흐름
값 20202021202220232024 TTM

Takeda Pharmaceutical Company Limited American Depositary Share

The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda.

뉴스